Aero Pump GmbH, Validose, Inc. and Ursatec GmbH today announced a collaboration to explore the usage of Validose´s biometrically secure intranasal medical device that optimizes drug delivery, prevents medication misuse and allows telemedicine and other digital facilitated control of the application, together with the market leading nasal spray systems from Aero Pump and Ursatec, targeting preserved and preservative-free nasal spray solutions. Marcel Botha, CEO of Validose stated: “The collaboration with two well established experts in nasal spray pump development and finished dosage manufacturing allows to support pharmaceutical partners over the whole product realisation cycle.” During the next months, the three companies will establish the implementation of the Aero Pump/Ursatec spray…